Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
2.
Climacteric ; 11(5): 373-82, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18781481

ABSTRACT

BACKGROUND: In postmenopausal women, an increase in insulin resistance is associated with an increased risk of diabetes, cardiovascular disease and breast cancer. Hormone replacement therapy (HRT) can reduce insulin resistance and coffee use is reported to decrease the incidence of diabetes. The aim of our study was to assess possible concurrent effects of HRT and espresso coffee intake on insulin resistance and on interdependent nutritional and clinical features. METHODS: A total of 478 healthy postmenopausal, non-diabetic women (aged 54.5 +/- 4.2 years) were studied: 360 had been on HRT for at least 2 years and 118 were not treated. Insulin resistance was assessed by a conventional homeostasis model (HOMA-IR). RESULTS: Insulin resistance is directly related to body mass index (p < 0.0001), and not with age and blood pressure; hypertensive menopausal women have a slightly higher body mass index but the same degree of insulin resistance as normotensive women. Women on HRT show lower insulin resistance, but not lower prevalence of arterial hypertension. Coffee use is associated with a decrease in insulin resistance in non-obese women receiving HRT, but not in other subsets. CONCLUSIONS: The combination of coffee consumption and HRT could lower insulin resistance in postmenopausal women. In overweight women, greater insulin sensitivity is associated with intake of espresso coffee and not with HRT; in normal weight women, only HRT is associated with lower insulin resistance.


Subject(s)
Coffee , Estrogen Replacement Therapy , Insulin Resistance , Postmenopause , Body Mass Index , Contraceptives, Oral, Synthetic/administration & dosage , Cross-Sectional Studies , Estradiol/administration & dosage , Estrogens/administration & dosage , Female , Humans , Hypertension/epidemiology , Megestrol/administration & dosage , Megestrol/analogs & derivatives , Middle Aged
3.
Eur Rev Med Pharmacol Sci ; 10(2): 69-74, 2006.
Article in English | MEDLINE | ID: mdl-16705951

ABSTRACT

Psychological stress has been implicated as a cause of several psychosomatic disorders, but also as a factor that can unfavourably influence many diseases including diabetes mellitus. Measure of psychological stress in diabetes was performed by Psychological Stress Measure (PSM), a validated instrument, designed using 49 items drawn from descriptors generated by focus groups on stress. Clinical and psychological framework was assessed in a cohort of 100 type 2 diabetic patients (30 m, 70 f), aged 66.99 +/- 13.68 years considering disease grade, complications and level of instruction. Three other questionnaires were administered concurrently to all patients: Sickness Impact Profile (SIP), Functional Living Index (FLI) and SF-36 QOL. ANOVA statistical testing and Spearman correlation matrix were used also vs socio-cultural and clinical profile. Gender, obesity, diet compliance, smoking do not affect PSM response. Hypertensive patients and those with family history of diabetes show lower PSM scores, according to a sort of moderator effect on stress of concurrent and/or previous experience with chronic disease. Neuromuscular ailments are more prevalent in women; men vs women experience severe limitations of their working capacities and relational possibilities, with severe discomfort. In the whole, higher scores of PSM (greater stress p < 0.01) and lower scores of FLI (fair well-being perception; p < 0.01) are reciprocally related inside any school instruction level. Despite the great reciprocal association of the PSM vs FLI and SIP, no significant correlation is found between PSM vs SF-36 QOL. Socio-cultural elements interfere, and particularly instruction level quantified as school grades achieved, with the manner of living their disease. Interventions on psychological distress of type 2 diabetes mellitus patients is warranted, specially in the groups with lower levels of instruction which may need an attentive strategy for achieving a satisfactory coping with this disease.


Subject(s)
Diabetes Mellitus, Type 2/psychology , Stress, Psychological/diagnosis , Aged , Diabetes Mellitus, Type 2/complications , Education , Female , Humans , Male , Psychological Tests , Quality of Life , Sex Factors , Socioeconomic Factors , Stress, Psychological/etiology , Surveys and Questionnaires
4.
Anticancer Res ; 19(2B): 1383-90, 1999.
Article in English | MEDLINE | ID: mdl-10365110

ABSTRACT

BACKGROUND: The optimal treatment for locoregionally recurrent rectal cancer after curative surgery has not yet been defined. The definition of prognostic factors could lead to the selection of an aggressive therapeutic approach in patients with favourable prognosis alone. PATIENTS AND METHODS: The records of thirty-nine ambulatory pts, 15 female and 24 male, with diagnosis of locoregionally recurrent rectal cancer (LRRC) after curative surgery and treated with radiotherapy were retrospectively analyzed. The following factors were analyzed for their ability to predict the clinical response and outcome for LRRC: age, sex, initial tumor grading, primary surgical approach, initial primary tumor stage according to Dukes' classification, disease free survival (time to primary surgery and detection of a LRRC), pelvic-perineal structure affected by recurrence, total radiation dose, chemotherapy with fluorouracil, symptomatic response to the therapy, locoregional symptomatic re-recurrence, systemic progression disease. RESULTS: In the univariate analysis, predictive factors for survival, were graded (G1-2 vs G3 p = 0.04), Dukes' stage at first diagnosis (A-B vs C p = 0.01), and site of pelvic-perineal recurrence (Pelvic mass alone yes vs no p = 0.01; Nerve and/or Osseous involvement yes vs no p < 0.001). Following therapy for LRRC, a better survival was observed in pts with a complete symptomatic response (complete remission vs partial remission vs no change p < 0.001), without a further locoregional symptomatic re-recurrence (re-recurrence, yes vs no p = 0.001) and/or appearance of metastatic disease (yes vs no p < 0.001).


Subject(s)
Antineoplastic Agents/therapeutic use , Fluorouracil/therapeutic use , Neoplasm Recurrence, Local/drug therapy , Rectal Neoplasms/surgery , Adult , Aged , Ambulatory Care , Analysis of Variance , Combined Modality Therapy , Female , Humans , Male , Middle Aged , Neoplasm Metastasis , Neoplasm Recurrence, Local/pathology , Neoplasm Recurrence, Local/radiotherapy , Neoplasm Staging , Prognosis , Radiotherapy Dosage , Rectal Neoplasms/pathology , Retrospective Studies , Survival Rate , Treatment Outcome
5.
Arch Androl ; 38(1): 23-8, 1997.
Article in English | MEDLINE | ID: mdl-9017119

ABSTRACT

The aim of this investigation was to study the pattern of luteinizing hormone (LH) secretion in men with mild and moderate hypertension. LH pulsatility was evaluated for 8 h in 14 male patients, subdivided into 2 groups; group A, consisting of 8 patients, whose systolic blood pressure ranged between 180 and 160 mm Hg and whose diastolic blood pressure was between 115 and 105 mm Hg; and group B, 6 patients whose systolic blood pressure ranged between 220 and 180 mm Hg and whose diastolic blood pressure was between 104 and 95 mm Hg. Seven healthy males were evaluated as controls (group C). The major changes of LH pulsatility in group A included an increased peak width, increased peak amplitude, and increased peak area. In group B the changes followed the same pattern as in group A, but were more pronounced. The number of LH peaks was reduced, the peak width was increased, and both peak amplitude and peak area were increased as compared to the control group. The pattern of LH pulsatility is altered in essential hypertension and the main feature is represented by the prolonged duration of LH peaks and their greater amplitude. The altered pattern of LH secretion is likely to reflect a primary hypothalamic derangement with the gonadotropin releasing hormone (Gn-RH) secreting neurons remaining synchronized for longer times and secreting larger Gn-RH masses than in normal subjects. Since the nuclei of the brain stem (A1-A6) involved in the control of Gn-RH secretion respond to blood pressure changes, the altered activity of monoaminergic neurons may be the link between hypertension and changes of LH pulsatility.


Subject(s)
Hypertension/blood , Luteinizing Hormone/blood , Adult , Blood Pressure , Humans , Luteinizing Hormone/metabolism , Male , Middle Aged , Pulsatile Flow
6.
Recenti Prog Med ; 87(2): 58-61, 1996 Feb.
Article in Italian | MEDLINE | ID: mdl-8725081

ABSTRACT

The pattern of luteinizing hormone (LH) secretion in men with mild and moderate hypertension was studied. LH pulsatility was evaluated for eight hours in 14 male patients, who were subdivided into two groups: group A, consisting of 8 patients, whose systolic blood pressure ranged between 180-160 mmHg and the diastolic between 104-95 mmHg; group B, 6 patients whose systolic blood pressure ranged between 220 and 180 mmHg and the diastolic between 115-105 mmHg. Seven healthy adult males were evaluated as a control. The major changes of LH pulsatility in group A included an increased peak width (p < 0.05), increased peak amplitude (p < 0.001) and increased peak area (p < 0.001). In group B the changes followed the same pattern as in group A, but were more pronounced. The number of LH peaks was reduced (p < 0.01), the peak width was increased (p < 0.05), and both peak amplitude and peak area were increased as compared to the control group (p < 0.001). Our study demonstrates that the pattern of LH pulsatility is altered in essential hypertension and the main feature is represented by the prolonged duration of LH peaks and their greater amplitude. The altered pattern of LH secretion is likely to reflect a primary hypothalamic derangement with the gonadotropin releasing hormone (Gn-RH) secreting neurons remaining synchronized for longer times and secreting larger Gn-RH masses than in normal subjects.


Subject(s)
Hypertension/blood , Luteinizing Hormone/drug effects , Luteinizing Hormone/metabolism , Adult , Antihypertensive Agents/therapeutic use , Humans , Hypertension/drug therapy , Luteinizing Hormone/blood , Male , Middle Aged
7.
J Cancer Res Clin Oncol ; 122(7): 416-20, 1996.
Article in English | MEDLINE | ID: mdl-8690752

ABSTRACT

The aim of this work was to characterize further the impairment of the reproductive function reported in untreated male patients with Hodgkin's disease. We evaluated the pattern of luteinizing hormone pulsatility and unconventional sperm features by computer-assisted sperm analysis (CASA) in 20 adult patients affected by biopsy-proven Hodgkin's disease before they were submitted to any therapeutic approach. Changes of luteinizing hormone pulsatility were documented and consisted mainly in an increase in pulse number in comparison with control subjects (P < 0.05). On CASA, 1/3 of the patients showed a reduction in the sperm number but, when motility, velocity and linearity of progression were evaluated, the number of patients with seminal alterations rose to 2/3. Sperm velocity and linearity were already impaired in stages I and II, whereas sperm number was reduced only in stage III. Symptomatic patients, regardless of the stage, showed a significant deterioration of all parameters. Our study supports the view that in Hodgkin's disease, before any treatment, a disorder of the reproductive system is present, both at hypothalamic/hypophysial and the gonadal level, having a pathogenesis that deserves to be elucidated by further study.


Subject(s)
Hodgkin Disease/blood , Hodgkin Disease/physiopathology , Luteinizing Hormone/blood , Spermatozoa/physiology , Adult , Humans , Hypothalamo-Hypophyseal System/physiopathology , Male , Middle Aged , Pulsatile Flow , Semen/cytology , Sperm Count , Sperm Motility , Spermatozoa/cytology
8.
J Steroid Biochem Mol Biol ; 43(5): 423-9, 1992 Oct.
Article in English | MEDLINE | ID: mdl-1327074

ABSTRACT

Sertoli cells play a pivotal role in the regulation of spermatogenesis as they provide the anatomical basis of the blood-testis barrier. In the present paper we report some results of our studies on the ultrastructural features, the responsiveness to FSH, and the ability to secrete androgen-binding protein (ABP) of human Sertoli cells in vitro. The nucleus showed the characteristic foldings of the nuclear membrane, scattered chromatin, and a fibrillar nucleolus. In the cytoplasm Charcot-Boettcher crystals were present and active phagocytic activity was documented by the presence of vacuoles containing lipids and cellular debris. Human Sertoli cells in culture responded to FSH with a maximal rise in cAMP that was approx. 3-fold. This response to FSH is comparable to that reported for the adult rat but lower than that of the immature rat, and suggests that human as well as rat Sertoli cells could have a reduced response to FSH since sexual maturation was achieved. As no evidence has been reported on ABP secretion by human Sertoli cells in culture we evaluated the concentration of this protein in the Sertoli cell spent media. Human Sertoli cells in culture produced ABP and the response to FSH was dose-related. The Kd value of human ABP (hABP) was approx. 7.5 nM, being slightly higher than that of the rat ABP and an order of magnitude different from that of sex hormone-binding globulin (SHBG) present in human plasma. We also measured the association and dissociation rates of dihydrotestosterone-hABP complexes and the Kd/Ka ratio was very close to the value of Kd of the Scatchard analysis. The differences between hABP and SHBG may open the way to the selective measurement of ABP in many conditions of male infertility.


Subject(s)
Androgen-Binding Protein/metabolism , Sertoli Cells/metabolism , Sertoli Cells/ultrastructure , Cyclic AMP/metabolism , Follicle Stimulating Hormone/pharmacology , Humans , In Vitro Techniques , Male , Microscopy, Electron
SELECTION OF CITATIONS
SEARCH DETAIL
...